Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent

Posted On May 31 2017 by

#epic pharma # Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 June 09, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. June 9, 2015 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing agreement with Epic Pharma LLC for ELI-200 (the “License”), an abuse-deterrent opioid utilizing Elite’s proprietary pharmacological abuse-deterrent technology. Epic will be responsible for sales and marketing of ELI-200, and Elite will be responsible for the manufacture of the product. Epic will pay Elite …


Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent

Posted On May 16 2017 by

#epic pharma # Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 June 09, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. June 9, 2015 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing agreement with Epic Pharma LLC for ELI-200 (the “License”), an abuse-deterrent opioid utilizing Elite’s proprietary pharmacological abuse-deterrent technology. Epic will be responsible for sales and marketing of ELI-200, and Elite will be responsible for the manufacture of the product. Epic will pay Elite …


Elite Pharmaceuticals Announces Changes to their Board of Directors Other OTC: ELTP #ajanta #pharma #products

Posted On May 16 2017 by

#epic pharma # Elite Pharmaceuticals Announces Changes to their Board of Directors April 12, 2016 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. April 12, 2016 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP ) announced today that its Board of Directors has appointed Eugene Pfeifer to its board effective April 7, 2016. At the same meeting, the Board accepted the resignation of Jeenarine Narine. Mr. Pfeifer brings with him more than 45 years of regulatory and trade experience, most recently having served as a law partner at King Spalding in Washington DC and prior to …


Other Pharmacy Events & Webinars – FIP – International Pharmaceutical Federation #pharmaceutical #companies

Posted On May 2 2017 by

#pharma conference # International Pharmaceutical Federation (FIP) Events and Webinars Chronic respiratory diseases (CRD), such as asthma and chronic obstructive pulmonary disease, kill more than four million people every year and affect hundreds of millions more. These diseases erode the health and well-being of the patients and have a negative impact on families and societies, and constitute a serious public health problem in all countries throughout the world. As an international federation of organisations of pharmacists, it is the mission and responsibility of FIP to address issues that broadly affect health and well-being across the globe. Despite the widespread assumption …


Elite Pharmaceuticals Announces Changes to their Board of Directors Other OTC: ELTP #amag #pharma

Posted On Mar 20 2017 by

#epic pharma # Elite Pharmaceuticals Announces Changes to their Board of Directors April 12, 2016 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. April 12, 2016 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP ) announced today that its Board of Directors has appointed Eugene Pfeifer to its board effective April 7, 2016. At the same meeting, the Board accepted the resignation of Jeenarine Narine. Mr. Pfeifer brings with him more than 45 years of regulatory and trade experience, most recently having served as a law partner at King Spalding in Washington DC and prior to …


Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent

Posted On Feb 1 2017 by

#epic pharma # Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 June 09, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. June 9, 2015 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing agreement with Epic Pharma LLC for ELI-200 (the “License”), an abuse-deterrent opioid utilizing Elite’s proprietary pharmacological abuse-deterrent technology. Epic will be responsible for sales and marketing of ELI-200, and Elite will be responsible for the manufacture of the product. Epic will pay Elite …


What can I do after completion of pharm D (doctor of pharmacy)? Is there any

Posted On Jan 16 2017 by

#pharma d # First i ll try to answer first part of your question. There are many things you can do after Pharm D, your qualification is never a barrier for your aspirations. You can almost do anything, we Indians are made to believe that if we find a job some time if at all it will be only related to our graduation, and finding a job not related to your education is impossible. It is definitely not easy but surely not impossible, so rather than just asking others what you can do, just ask yourself what do you want …


Other Pharmacy Events & Webinars – FIP – International Pharmaceutical Federation #pharma #info

Posted On Jan 10 2017 by

#pharma conference # International Pharmaceutical Federation (FIP) Events and Webinars Chronic respiratory diseases (CRD), such as asthma and chronic obstructive pulmonary disease, kill more than four million people every year and affect hundreds of millions more. These diseases erode the health and well-being of the patients and have a negative impact on families and societies, and constitute a serious public health problem in all countries throughout the world. As an international federation of organisations of pharmacists, it is the mission and responsibility of FIP to address issues that broadly affect health and well-being across the globe. Despite the widespread assumption …


Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent

Posted On Dec 14 2016 by

#epic pharma # Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200 June 09, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. June 9, 2015 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing agreement with Epic Pharma LLC for ELI-200 (the “License”), an abuse-deterrent opioid utilizing Elite’s proprietary pharmacological abuse-deterrent technology. Epic will be responsible for sales and marketing of ELI-200, and Elite will be responsible for the manufacture of the product. Epic will pay Elite …


Elite Pharmaceuticals Announces Changes to their Board of Directors Other OTC: ELTP #pharmaceutical #products

Posted On Dec 10 2016 by

#epic pharma # Elite Pharmaceuticals Announces Changes to their Board of Directors April 12, 2016 08:00 ET | Source: Elite Pharmaceuticals, Inc. NORTHVALE, N.J. April 12, 2016 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP ) announced today that its Board of Directors has appointed Eugene Pfeifer to its board effective April 7, 2016. At the same meeting, the Board accepted the resignation of Jeenarine Narine. Mr. Pfeifer brings with him more than 45 years of regulatory and trade experience, most recently having served as a law partner at King Spalding in Washington DC and prior to …